Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients

International Journal of Radiation Oncology, Biology, Physics, Volume 98, Issue 5, 2017 Aug 1 | Kim, Kelly Y., PhD; Le, Quynh-Thu, MD; Yom, Sue S., MD, PhD;...
Introduction Epstein-Barr virus (EBVacrnm1) exposure is ubiquitous, with over 90% of adults worldwide infected and seropositive for Epstein-Barr virus, which generally establishes itself in B cells (1) . It is well known to cause infectious mononu...

http://ift.tt/2tijlze